Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

NIH researchers identify new genetic risk factors for two types of non-Alzheimer's dementia

Scientists at the National Institutes of Health have identified new genetic risk factors for two types of non-Alzheimer's dementia.

8 May 2023

GlyNAC supplementation plays beneficial role in promoting brain health and cognitive function in aging

As people get older, they aspire to live healthy lives as free as possible from the natural decline of cognitive abilities that occurs with aging.

5 May 2023

Membrane lipid remodeling alters key enzyme involved in Alzheimer’s

Adding long-chain fatty acids can thicken cell membranes and alter the activity of a key enzyme, as LMU scientists have demonstrated in cell cultures.

4 May 2023

Eli Lilly trial reveals Alzheimer's drug that significantly slows cognitive decline

Study examined the safety and efficacy of the study drug donanemab in participants with early Alzheimer's disease (AD).

4 May 2023

A deep slumber may help buffer Alzheimer’s-related memory issues

A deep slumber might help buffer against memory loss for older adults facing a heightened burden of Alzheimer's disease, new research from the University of California, Berkeley, suggests.

4 May 2023

Genetics can boost and complicate dementia risk linked to air pollution exposure

Three years ago, an international study commissioned by the journal Lancet listed 12 modifiable factors that increased the risk of dementia, including three new ones: excessive alcohol, head injury and air pollution.

3 May 2023

FAU and Insightec collaborate to use focused ultrasound to treat brain diseases

During his trade mission trip to Israel, Florida Gov. Ron DeSantis announced a new agreement between Florida Atlantic University and Insightec, a global health care company headquartered in Haifa, Israel.

2 May 2023

Multiple co-occurring sensory impairments may increase the risk of dementia

Emerging science shows that sensory dysfunction can increase the risk of dementia, and the new research presented at AAIC 2019 further demonstrates the impact of multiple co-occurring sensory impairments.

2 May 2023

Gum Health Day 2023 campaign focuses on aesthetics and wellbeing

Keeping gums healthy and regularly checked is an integral part of everybody's general health as scientific evidence shows a clear association between gum disease and many serious, chronic conditions including diabetes, cardiovascular disease.

25 Apr 2023

Researchers uncover the molecular basis for making long-term memories

Helping your mother make pancakes when you were three…riding your bike without training wheels…your first romantic kiss: How do we retain vivid memories of long-ago events? As described in a paper published online on April 25 in Neuron, researchers at Albert Einstein College of Medicine have found the explanation.

25 Apr 2023

Exposure to polycyclic aromatic hydrocarbons promotes the progression of Alzheimer's disease

Polycyclic aromatic hydrocarbons (PAHs) are typical organic compounds found in cigarette smoke and vehicle exhaust. In addition, PAHs are produced from incomplete combustion of organic material and cooking.

24 Apr 2023

Study shows how the brain benefits from consistently lower blood pressure

Intensive blood pressure treatment significantly reduces the risk of adverse cerebrovascular events such as stroke.

24 Apr 2023

Targeting antiviral pathway may offer a new approach to fight Alzheimer's, frontotemporal dementia

Targeting part of an antiviral pathway triggered by the accumulation of a key pathogen shared in Alzheimer's disease and frontotemporal dementia may one day offer a new therapeutic approach to deterring or delaying cognitive decline, according to preclinical research led by Weill Cornell Medicine scientists.

24 Apr 2023

Mount Sinai announces creation of the Institute for Regenerative Medicine

Regenerative medicine - the process of replacing, engineering or regenerating human cells, tissues or organs - holds exciting potential for the field of health care.

24 Apr 2023

U-M to launch a population-based study on Alzheimer’s disease and related dementias in India

The University of Michigan is looking to launch a population-based study on Alzheimer’s disease and related dementias in India.

21 Apr 2023

Research reveals a more effective treatment for multiple sclerosis patients

Degeneration of myelin, an insulating sheath required for rapid communication between nerve cells, and neuroinflammation are notable hallmarks of Multiple Sclerosis (MS) and related neurodegenerative disorders such as Alzheimer's disease or Huntington's disease that affect roughly 2.8 million people in the world.

21 Apr 2023

Study hints at the potential of sleep pills to slow or stop Alzheimer's disease progression

Sleep disturbances can be an early sign of Alzheimer's disease. Many people eventually diagnosed with Alzheimer's start experiencing difficulty falling and staying asleep years before cognitive problems such as memory loss and confusion emerge.

20 Apr 2023

Study links astrocytic TDP-43 dysfunction to cognitive decline in dementia: Unlocking potential therapeutic strategies

...

20 Apr 2023

Neighborhood social factors may be linked to epilepsy outcomes

People with epilepsy living in disadvantaged neighborhoods - areas with higher poverty levels and fewer educational and employment opportunities - may be more likely to have memory, thinking, and mental health problems compared to people with epilepsy living in neighborhoods with fewer disadvantages, according to new research published in the April 19, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

20 Apr 2023

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease.

20 Apr 2023

Alzheimer's Disease News and Research

Further Reading

NIH researchers identify new genetic risk factors for two types of non-Alzheimer's dementia

GlyNAC supplementation plays beneficial role in promoting brain health and cognitive function in aging

Membrane lipid remodeling alters key enzyme involved in Alzheimer’s

Eli Lilly trial reveals Alzheimer's drug that significantly slows cognitive decline

A deep slumber may help buffer Alzheimer’s-related memory issues

Genetics can boost and complicate dementia risk linked to air pollution exposure

FAU and Insightec collaborate to use focused ultrasound to treat brain diseases

Multiple co-occurring sensory impairments may increase the risk of dementia

Gum Health Day 2023 campaign focuses on aesthetics and wellbeing

Researchers uncover the molecular basis for making long-term memories

Exposure to polycyclic aromatic hydrocarbons promotes the progression of Alzheimer's disease

Study shows how the brain benefits from consistently lower blood pressure

Targeting antiviral pathway may offer a new approach to fight Alzheimer's, frontotemporal dementia

Mount Sinai announces creation of the Institute for Regenerative Medicine

U-M to launch a population-based study on Alzheimer’s disease and related dementias in India

Research reveals a more effective treatment for multiple sclerosis patients

Study hints at the potential of sleep pills to slow or stop Alzheimer's disease progression

Study links astrocytic TDP-43 dysfunction to cognitive decline in dementia: Unlocking potential therapeutic strategies

Neighborhood social factors may be linked to epilepsy outcomes

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News